Baird Financial Group Inc. trimmed its holdings in ICU Medical, Incorporated (NASDAQ:ICUI) by 21.0% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 39,340 shares of the medical instruments supplier’s stock after selling 10,441 shares during the quarter. Baird Financial Group Inc. owned 0.19% of ICU Medical worth $11,055,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Cerebellum GP LLC bought a new stake in shares of ICU Medical in the 3rd quarter worth approximately $186,000. Mackay Shields LLC bought a new stake in ICU Medical during the 2nd quarter valued at $205,000. CIBC Asset Management Inc bought a new stake in ICU Medical during the 2nd quarter valued at $209,000. MML Investors Services LLC bought a new stake in ICU Medical during the 3rd quarter valued at $217,000. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new stake in ICU Medical during the 2nd quarter valued at $235,000. Hedge funds and other institutional investors own 74.49% of the company’s stock.
NASDAQ:ICUI opened at $240.49 on Friday. ICU Medical, Incorporated has a 52 week low of $201.65 and a 52 week high of $321.70. The firm has a market cap of $4.95 billion, a P/E ratio of 43.57 and a beta of 0.65.
ICUI has been the subject of a number of recent analyst reports. Zacks Investment Research lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Saturday, November 10th. ValuEngine lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday, September 18th. BidaskClub lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 8th. Finally, TheStreet upgraded shares of ICU Medical from a “c+” rating to a “b+” rating in a report on Monday, August 20th.
In other ICU Medical news, Director Pfizer Inc sold 2,500,000 shares of the business’s stock in a transaction on Thursday, November 15th. The shares were sold at an average price of $209.25, for a total transaction of $523,125,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 12.50% of the stock is currently owned by insiders.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Read More: Swap
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.